Article
Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>
2024-12-14
Abstract excerpt
<h4>Background</h4> South Africa has high sexually transmitted infections (STIs) prevalence and currently implement syndromic management, which has limitations such as untreated asymptomatic infections and antibiotic misuse. Diagnostic tools, like GeneXpert may offer potential improvements. We evaluated costs, cost-effectiveness and budget impact of reallocating GeneXpert capacity for STIs testing. <h4>Methods</h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9f85abf7-683a-55ae-b5f0-48352280c8ba
- DOI
- 10.1101/2024.12.13.24319006
